Salix Pharmaceuticals

Activities: Digestion Pharmaceutical

Trending Articles

  1. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
  5. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Finance

Valeant increases offer for Salix to US$15.8bn in cash

Endo withdraws its offer for the US manufacturer of gastrointestinal drugs
Finance

Endo submits offer to purchase Salix Pharmaceuticals for about US$15.7bn

Higher bid than Valeant's offer of $14.5bn in February
Finance

Valeant to buy Salix Pharmaceuticals for US$14.5bn

Adding gastrointestinal products to its dermatology, eye health and neurology portfolio
Finance

Salix Pharmaceuticals and Cosmo Technologies call off merger

Will make a US$25m payment to Cosmo for terminating the deal
Subscribe now